33 related articles for article (PubMed ID: 18367108)
1. Nuclear Inositides and Inositide-Dependent Signaling Pathways in Myelodysplastic Syndromes.
Xian J; Owusu Obeng E; Ratti S; Rusciano I; Marvi MV; Fazio A; De Stefano A; Mongiorgi S; Cappellini A; Ramazzotti G; Manzoli L; Cocco L; Follo MY
Cells; 2020 Mar; 9(3):. PubMed ID: 32178280
[TBL] [Abstract][Full Text] [Related]
2. Expression of Hepatocyte Growth Factor-Like Protein in Human Wound Tissue and Its Biological Functionality in Human Keratinocytes.
Glasbey JC; Sanders AJ; Bosanquet DC; Ruge F; Harding KG; Jiang WG
Biomedicines; 2015 Feb; 3(1):110-123. PubMed ID: 28536402
[TBL] [Abstract][Full Text] [Related]
3. Lentivirus-mediated PLCγ1 gene short-hairpin RNA suppresses tumor growth and metastasis of human gastric adenocarcinoma.
Zhang B; Wang F; Dai L; Cai H; Zhan Y; Gang S; Hu T; Xia C; Zhang B
Oncotarget; 2016 Feb; 7(7):8043-54. PubMed ID: 26811493
[TBL] [Abstract][Full Text] [Related]
4. WISP-2 in human gastric cancer and its potential metastatic suppressor role in gastric cancer cells mediated by JNK and PLC-γ pathways.
Ji J; Jia S; Jia Y; Ji K; Hargest R; Jiang WG
Br J Cancer; 2015 Sep; 113(6):921-33. PubMed ID: 26291058
[TBL] [Abstract][Full Text] [Related]
5. Stromal cell-derived factor-1 signaling via the CXCR4-TCR heterodimer requires phospholipase C-β3 and phospholipase C-γ1 for distinct cellular responses.
Kremer KN; Clift IC; Miamen AG; Bamidele AO; Qian NX; Humphreys TD; Hedin KE
J Immunol; 2011 Aug; 187(3):1440-7. PubMed ID: 21705626
[TBL] [Abstract][Full Text] [Related]
6. RasGRP3 contributes to formation and maintenance of the prostate cancer phenotype.
Yang D; Kedei N; Li L; Tao J; Velasquez JF; Michalowski AM; Tóth BI; Marincsák R; Varga A; Bíró T; Yuspa SH; Blumberg PM
Cancer Res; 2010 Oct; 70(20):7905-17. PubMed ID: 20876802
[TBL] [Abstract][Full Text] [Related]
7. Molecular circuits shared by placental and cancer cells, and their implications in the proliferative, invasive and migratory capacities of trophoblasts.
Ferretti C; Bruni L; Dangles-Marie V; Pecking AP; Bellet D
Hum Reprod Update; 2007; 13(2):121-41. PubMed ID: 17068222
[TBL] [Abstract][Full Text] [Related]
8. A discourse on cancer cell chemotaxis: where to from here?
Soon LL
IUBMB Life; 2007 Feb; 59(2):60-7. PubMed ID: 17454296
[TBL] [Abstract][Full Text] [Related]
9. Expression of the prostate transglutaminase (TGase-4) in prostate cancer cells and its impact on the invasiveness of prostate cancer.
Davies G; Ablin RJ; Mason MD; Jiang WG
J Exp Ther Oncol; 2007; 6(3):257-64. PubMed ID: 17552366
[TBL] [Abstract][Full Text] [Related]
10. Targeting the HGF/SF receptor c-met using a hammerhead ribozyme transgene reduces in vitro invasion and migration in prostate cancer cells.
Davies G; Watkins G; Mason MD; Jiang WG
Prostate; 2004 Sep; 60(4):317-24. PubMed ID: 15264243
[TBL] [Abstract][Full Text] [Related]
11. Endogenous bone morphogenetic protein-7 controls the motility of prostate cancer cells through regulation of bone morphogenetic protein antagonists.
Ye L; Lewis-Russell JM; Kynaston H; Jiang WG
J Urol; 2007 Sep; 178(3 Pt 1):1086-91. PubMed ID: 17644136
[TBL] [Abstract][Full Text] [Related]
12. A role for phospholipase C-gamma-mediated signaling in tumor cell invasion.
Kassis J; Moellinger J; Lo H; Greenberg NM; Kim HG; Wells A
Clin Cancer Res; 1999 Aug; 5(8):2251-60. PubMed ID: 10473113
[TBL] [Abstract][Full Text] [Related]
13. Effect of hepatocyte growth factor on invasion of prostate cancer cell lines.
Fujiuchi Y; Nagakawa O; Murakami K; Fuse H; Saiki I
Oncol Rep; 2003; 10(4):1001-6. PubMed ID: 12792760
[TBL] [Abstract][Full Text] [Related]
14. Phospholipase-C gamma-1 (PLCgamma-1) is critical in hepatocyte growth factor induced in vitro invasion and migration without affecting the growth of prostate cancer cells.
Davies G; Martin TA; Ye L; Lewis-Russell JM; Mason MD; Jiang WG
Urol Oncol; 2008; 26(4):386-91. PubMed ID: 18367108
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
